Summary Retatrutide, a triple agonist now in phase 3 trials, has the potential to become the most effective pharmacological treatment for obesity while also offering substantial benefits in T2D management and other cardiometabolic risk factors
The mechanism of action of semaglutide involves mimicking the effects of the naturally occurring hormone GLP-1
Patients who use food as a coping mechanism for stress, anxiety, or depression may continue these patterns despite reduced physiological hunger, consuming calories beyond their body's needs
Hims & Hers is mass marketing unapproved knock-off versions of Wegovy and Ozempic that evade the FDAs gold standard review process thats dangerous and deceptive to patients, and undermines the scientific innovation and regulatory rigor in place to ensure these treatments are safe and effective, said John F
Insulin-nave adult patients (N=271) with T2DM receiving GLP-1 RA therapy OAD(s) that was subsequently intensified by adding Toujeo